10-Q: CLS Holdings USA Reports Q2 2024 Results: Revenue Declines Amidst Market Challenges, Debt Restructuring Efforts Underway

CLS Holdings USA reported a decrease in revenue for the second quarter of fiscal year 2024, alongside ongoing efforts to restructure debt and improve financial stability.

Summary

• CLS Holdings USA reported a revenue of $5.2 million for the three months ended November 30, 2023, a 14% decrease compared to the same period last year.
• The company's dispensary revenue decreased by 18% to $3.1 million, while cannabis production revenue fell by 8% to $2.1 million.
• The cost of goods sold was $3.0 million, resulting in a gross margin of 41.8%, down from 48.2% in the prior year.
• Selling, general, and administrative expenses decreased by 24% to $2.6 million due to cost-cutting measures.
• The net loss for the quarter was $1.3 million, a significant improvement from the $8.2 million loss in the same period last year.
• For the six months ended November 30, 2023, revenue was $10.3 million, a 15% decrease year-over-year.
• The company's net loss for the six-month period was $1.8 million, compared to a $9.5 million loss in the prior year.
• The company has a working capital deficit of $14 million as of November 30, 2023.
• CLS Holdings is actively restructuring its debt, including converting some debt to equity and negotiating new financing.
• The company has generated positive cash flow from operating activities for the last four quarters.

Sentiment

Score: 4

Explanation: The document shows a mixed picture. While there are improvements in net loss and operating expenses, the significant revenue decline, working capital deficit, and ongoing debt restructuring efforts indicate substantial financial challenges. The company is taking steps to improve its financial position, but the overall sentiment is cautiously negative.

Positives

• The company's net loss improved significantly, decreasing from $8.2 million to $1.3 million for the quarter.
• Selling, general, and administrative expenses were reduced by 24% due to cost-cutting efforts.
• The company has generated positive cash flow from operating activities for the last four quarters.
• The company is actively restructuring its debt, which includes converting some debt to equity and negotiating new financing.
• The company has reduced its interest expense by 33% for the three months ended November 30, 2023.

Negatives

• Revenue decreased by 14% to $5.2 million for the three months ended November 30, 2023, compared to the same period last year.
• The company's dispensary revenue decreased by 18% to $3.1 million.
• The company's cannabis production revenue fell by 8% to $2.1 million.
• The company's gross margin decreased from 48.2% to 41.8%.
• The company has a working capital deficit of $14 million as of November 30, 2023.

Risks

• The company faces challenges in the cannabis market, including decreased wholesale pricing and a slowdown in nonessential expenditures.
• The company has a significant working capital deficit of $14 million.
• The company's ability to continue as a going concern is dependent on its ability to generate sufficient cash from operations or obtain necessary financing.
• The company is subject to Section 280E of the Internal Revenue Code, which limits the deductibility of certain expenses.
• The company is exposed to the effects of climate change, which could impact crop quality and increase energy costs.

Future Outlook

The company expects revenue to grow as operations expand, and anticipates sufficient capital through internal cash generation, debt/equity sales, and debt conversion. The company is also in negotiations to obtain an additional $2,000,000 in loans.

Management Comments

• Management intends to finance operating costs over the next twelve months with revenues from operations.
• Management believes that EBITDA provides relevant and useful information, which is widely used by analysts, investors and competitors in our industry as well as by our management.
• Management also believes that adjusting EBITDA for the effects of non-recurring transactions may provide insight into the nature of the core business.

Industry Context

The company is operating in a challenging cannabis market with decreased wholesale pricing and a slowdown in nonessential expenditures. The company is attempting to create a gold standard national brand by standardizing the testing, compliance and labeling of its products in an industry currently comprised of small, local businesses with erratic and unreliable product quality, testing practices and labeling.

Comparison to Industry Standards

• The company's revenue decline of 14% for the quarter and 15% for the six months is worse than the industry average, which has seen growth in many markets.
• The company's gross margin of 41.8% for the quarter is below the industry average, which is typically in the range of 50-60% for established cannabis companies.
• The company's net loss of $1.3 million for the quarter is better than the $8.2 million loss in the same period last year, but still indicates financial challenges.
• The company's working capital deficit of $14 million is a significant concern compared to industry peers, which typically have positive working capital.
• Compared to companies like Curaleaf and Trulieve, which have significant scale and positive cash flow, CLS Holdings is still in a turnaround phase.
• The company's debt restructuring efforts are similar to other cannabis companies facing financial difficulties, but the success of these efforts remains to be seen.

Legal Proceedings

• The company is involved in a legal dispute with Integrity Global Security Inc., which is currently stayed pending a Judicial Settlement Conference.
• The company reached agreements with IGS on January 2, 2024, whereby the company will pay $55,000 in settlement of all claims against the company, and IGS will pay the company $10,000 in settlement of all claims against IGS.

Related Party Transactions

• The company had accrued salary due to Michael Abrams, a former officer, in the amount of $16,250.
• The company made payments of $10,000 to each of its three directors for their participation on the Board, for a total of $30,000.
• The company authorized a bonus for its Chief Executive Officer in the amount of $50,000.
• The company accrued interest in the amount of $72,071 on a convertible note payable to Navy Capital Green Co-Invest Fund, LLC.

Stakeholder Impact

• Shareholders face the risk of further dilution due to potential equity issuances.
• Employees may be affected by ongoing cost-cutting measures.
• Customers may experience changes in product availability or pricing due to market conditions.
• Suppliers may be impacted by the company's financial challenges and debt restructuring efforts.
• Creditors face the risk of potential losses due to the company's debt restructuring efforts.

Next Steps

• The company will continue to restructure its debt, including converting some debt to equity.
• The company will continue to negotiate new financing.
• The company will continue to focus on cost control measures.
• The company will continue to explore opportunities for growth through acquisitions and joint ventures.

Key Dates

Keywords

cannabis, dispensary, cultivation, extraction, debt restructuring, financial results, revenue, net loss, working capital, operating expenses